AKT1 and esophageal adenocarcinoma: Consistently, genetic silencing of AKT or pharmacological inhibition of PI3K-AKT signaling downregulates GLI1 in human esophageal adenocarcinoma (EAC) cells (Kebenko et al., 2015).